The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study

While much has been learned about the epidemiology and treatment of end-stage renal disease (ESRD) in the last 30 years, chronic kidney disease (CKD) before the end-stage has been less investigated. Not enough is known about factors associated with CKD progression and complications, as well as its t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nephrology, dialysis, transplantation Ročník 29; číslo 8; s. 1500
Hlavní autoři: Stengel, Bénédicte, Combe, Christian, Jacquelinet, Christian, Briançon, Serge, Fouque, Denis, Laville, Maurice, Frimat, Luc, Pascal, Christophe, Herpe, Yves-Edouard, Deleuze, Jean-François, Schanstra, Joost, Pisoni, Ron L, Robinson, Bruce M, Massy, Ziad A
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.08.2014
Témata:
Adult
Aged
Disease Progression
Female
Follow-Up Studies
France - epidemiology
Humans
Incidence
Information Services
Male
Middle Aged
Prospective Studies
Renal Insufficiency, Chronic - epidemiology
Renal Insufficiency, Chronic - therapy
Renal Replacement Therapy - methods
Time Factors
France
clinical practice
cohort
chronic kidney disease
quality of life
biomarkers
ISSN:1460-2385, 1460-2385
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:While much has been learned about the epidemiology and treatment of end-stage renal disease (ESRD) in the last 30 years, chronic kidney disease (CKD) before the end-stage has been less investigated. Not enough is known about factors associated with CKD progression and complications, as well as its transition to ESRD. We designed the CKD-renal epidemiology and information network (REIN) cohort to provide a research platform to address these key questions and to assess clinical practices and costs in patients with moderate or advanced CKD. A total of 46 clinic sites and 4 renal care networks participate in the cohort. A stratified selection of clinic sites yields a sample that represents a diversity of settings, e.g. geographic region, and public versus for-profit and non-for-profit private clinics. In each site, 60-90 patients with CKD are enrolled at a routine clinic visit during a 12-month enrolment phase: 3600 total, including 1800 with Stage 3 and 1800 with Stage 4 CKD. Follow-up will continue for 5 years, including after initiation of renal replacement therapy. Data will be collected from medical records at inclusion and at yearly intervals, as well as from self-administered patient questionnaires and provider-level questionnaires. Patients will also be interviewed at baseline, and at 1, 3 and 5 years. Healthcare costs will also be determined. Blood and urine samples will be collected and stored for future studies on all patients at enrolment and at study end, and at 1 and 3 years in a subsample of 1200. The CKD-REIN cohort will serve to improve our understanding of the biological, clinical and healthcare system determinants associated with CKD progression and adverse outcomes as well as of international variations in collaboration with the CKD Outcome and Practice Pattern Study (CKDopps). It will foster CKD epidemiology and outcomes research and provide evidence to improve the health and quality of life of patients with CKD and the performances of the healthcare system in this field.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1460-2385
1460-2385
DOI:10.1093/ndt/gft388